Best PJ - Search Results

1

Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia.

Herrmann J, Best PJ, Ritman EL, Holmes DR, Lerman LO, Lerman A. Herrmann J, et al. Among authors: best pj. J Am Coll Cardiol. 2002 May 1;39(9):1555-61. doi: 10.1016/s0735-1097(02)01798-9. J Am Coll Cardiol. 2002. PMID: 11985922 Free article.

2

Acute endothelin-receptor inhibition does not attenuate acetylcholine-induced coronary vasoconstriction in experimental hypercholesterolemia.

Hasdai D, Best PJ, Cannan CR, Mathew V, Schwartz RS, Holmes DR Jr, Lerman A. Hasdai D, et al. Among authors: best pj. Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):108-13. doi: 10.1161/01.atv.18.1.108. Arterioscler Thromb Vasc Biol. 1998. PMID: 9445263

3

The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women.

Best PJ, Berger PB, Miller VM, Lerman A. Best PJ, et al. Ann Intern Med. 1998 Feb 15;128(4):285-8. doi: 10.7326/0003-4819-128-4-199802150-00006. Ann Intern Med. 1998. PMID: 9471931

4

Apoptosis. Basic concepts and implications in coronary artery disease.

Best PJ, Hasdai D, Sangiorgi G, Schwartz RS, Holmes DR Jr, Simari RD, Lerman A. Best PJ, et al. Arterioscler Thromb Vasc Biol. 1999 Jan;19(1):14-22. doi: 10.1161/01.atv.19.1.14. Arterioscler Thromb Vasc Biol. 1999. PMID: 9888861 Review.

5

Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia.

Best PJ, McKenna CJ, Hasdai D, Holmes DR Jr, Lerman A. Best PJ, et al. Circulation. 1999 Apr 6;99(13):1747-52. doi: 10.1161/01.cir.99.13.1747. Circulation. 1999. PMID: 10190886

6

In vivo renal vascular and tubular function in experimental hypercholesterolemia.

Feldstein A, Krier JD, Sarafov MH, Lerman A, Best PJ, Wilson SH, Lerman LO. Feldstein A, et al. Among authors: best pj. Hypertension. 1999 Oct;34(4 Pt 2):859-64. doi: 10.1161/01.hyp.34.4.859. Hypertension. 1999. PMID: 10523374

7

Coronary endothelial function is preserved with chronic endothelin receptor antagonism in experimental hypercholesterolemia in vitro.

Best PJ, Lerman LO, Romero JC, Richardson D, Holmes DR Jr, Lerman A. Best PJ, et al. Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2769-75. doi: 10.1161/01.atv.19.11.2769. Arterioscler Thromb Vasc Biol. 1999. PMID: 10559024

8

Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia.

Wilson SH, Best PJ, Lerman LO, Holmes DR Jr, Richardson DM, Lerman A. Wilson SH, et al. Among authors: best pj. Cardiovasc Res. 1999 Dec;44(3):601-7. doi: 10.1016/s0008-6363(99)00225-4. Cardiovasc Res. 1999. PMID: 10690293

9

Endothelin in cardiovascular disease: from atherosclerosis to heart failure.

Best PJ, Lerman A. Best PJ, et al. J Cardiovasc Pharmacol. 2000;35(4 Suppl 2):S61-63. doi: 10.1097/00005344-200000002-00014. J Cardiovasc Pharmacol. 2000. PMID: 10976784 Review.

10

Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia.

Rodriguez-Porcel M, Lerman A, Ritman EL, Wilson SH, Best PJ, Lerman LO. Rodriguez-Porcel M, et al. Among authors: best pj. Circulation. 2000 Oct 24;102(17):2028-30. doi: 10.1161/01.cir.102.17.2028. Circulation. 2000. PMID: 11044415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters